Analyst Ratings for Indaptus Therapeutics (INDP)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/31/2022 | H.C. Wainwright » Updated 10/16/2024 |
Raghuram Selvaraju | New Coverage | Buy (N/A) |
12.00 (N/A) |
4.59 (4.75) |
3.49% | Details |
| 10/19/2021 | Maxim Group » Updated 11/13/2024 |
Jason McCarthy | Upgrade | Buy (Hold) |
5.00 (8.00) |
7.54 (4.75) |
-37% | Details |
